Clinical Trial Update: A Study in Patients With Mixed Dyslipidemia [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial addressing mixed dyslipidemia that is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mixed Dyslipidemia

Snippet

Sponsor: Shanghai Argo Biopharmaceutical Co., Ltd. | Conditions: Mixed Dyslipidemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING